"By Isomorphic Labs, a company founded by Demis Hassabis, which uses frontier artificial intelligence (AI) for drug design and development, has received investment from the UK government's Sovereign AI fund."
"Launched in April, the Sovereign AI fund provides grants of £1m up to £9m to fund the creation of strategic AI assets. The programme is initially aimed at high-value AI datasets and autonomous or automated laboratory infrastructure. It is open to UK-registered companies, research organisations, universities and consortia with a credible plan that aligns with the Sovereign AI focus areas."
"Isomorphic's work builds on the breakthrough success of DeepMind's AlphaFold, the AI model co-created by Hassabis that demonstrated in 2016 how AI could beat the Go world champion, Leo Sedol."
"The company is developing a number of proprietary breakthrough AI models, which together form its unified drug design engine across multiple therapeutic areas and drug modalities."
Isomorphic Labs, founded by Demis Hassabis, received investment from the UK government’s Sovereign AI fund. The company uses frontier AI for drug design and development and builds on AlphaFold’s breakthrough success. Isomorphic is developing proprietary AI models that together form a unified drug design engine across multiple therapeutic areas and drug modalities. The Sovereign AI fund, launched in April, provides grants ranging from £1 million to £9 million to create strategic AI assets. The program targets high-value AI datasets and autonomous or automated laboratory infrastructure. It is open to UK-registered companies, research organizations, universities, and consortia with credible plans aligned to the fund’s focus areas, aiming to secure long-term strategic advantage for the UK.
Read at ComputerWeekly.com
Unable to calculate read time
Collection
[
|
...
]